Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Prospective Non Interventional Phase IV Multi-centre Canadian Study on the Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion Under 63 Days Gestation

Next Previous
Trial Profile

Prospective Non Interventional Phase IV Multi-centre Canadian Study on the Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion Under 63 Days Gestation

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mifepristone/misoprostol (Primary)
  • Indications Induced abortion
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms MiMAC
  • Sponsors Linepharma International Limited

Most Recent Events

  • 10 Feb 2025 Status changed from recruiting to discontinued, due to insufficient recruitment for doing a meaningful analysis and inconclusive data collection. Required number of subjects were not likely to get enrolled within the 2 years timeframe, that the trial was planned to continue.
  • 16 Aug 2022 Status changed from not yet recruiting to recruiting.
  • 27 Nov 2021 Planned initiation date changed from 15 Jul 2021 to 31 Dec 2021.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top